Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Our Compounding Knowledge, Your Peace of Mind
April 8, 2016  |  Volume 13  |  Issue 14
IN THIS ISSUE
 
SUBSCRIPTIONS / INFO
 
CLASSIFIEDS
 
ABOUT COMPOUNDINGTODAY
 
FREE RESOURCES
 
SUBSCRIBER RESOURCES
EXAKT 50EC+ : For the Serious Compounder
Five Compounding Pharmacies for Sale
Receive a free compounding CD with new subscription to IJPC.
Spectrum Pharmacy Products
 
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
Implementing United States Pharmacopeia <800>, Part 9: Hazardous Drugs-Handling in Healthcare Settings

(Learning about USP Chapter <800> in 10 minutes a week.)

5. Facilities and Engineering Controls

5.3.1 NONSTERILE Compounding

C-PEC

  • A C-PEC is not required if only handling "final dosage forms" (counting, repackaging, etc.) that do not produce particles, aerosols, or gasses.
  • C-PECs for nonsterile (NS) HDs must be either:
    • Externally vented (preferred), OR
    • Have redundant-HEPA filters in series.
  • C-PECs include:
    • Class I Biological Safety Cabinets (BSC)
    • Containment Ventilated Enclosure (CVE)
    • Class II BSC or a Compounding Aseptic Containment Isolator (CACI)
  • For occasional NS HD compounding, a C-PEC for Sterile may be used but must be decontaminated, cleaned and disinfected before resuming sterile compounding.
  • C-PEC for NS HD compounding does NOT require unidirectional airflow as it is not "classified air."

C-SEC

  • The C-SEC where the C-PEC is located must have at least 12 air changes per hour (ACPH).
  • The surfaces of
    • ceilings,
    • walls,
    • floors,
    • fixtures,
    • shelving,
    • counters and
    • cabinets
  • must be
    • smooth,
    • impervious,
    • free from cracks and crevices and be
    • nonshedding.
  • The C-SEC must be
    • Externally vented
    • 12 ACHP
    • Negative pressure between 0.01 and 0.03 inches of water column relative to adjacent areas.

NEXT WEEK:

5.3.2 Sterile Compounding

QUESTIONS RECIEVED FROM PHARMACISTS:

The following is a list of "unanswered questions" that need answers ASAP, as time is wasting. If you have a valid/documented answer, please send it to me at lallen@ijpc.com so we can post it. Thanks.

INTRODUCTION AND SCOPE

  1. What is potentially covered in the phrase "not limited to"?
  2. Does "included personnel" also include drivers, custodians, inspectors, etc.?
  3. Is the patient bedside included in administration?
  4. Regarding transport, can HDs be transported in tubes, robots, patient carts, etc.? If so, which ones?
  5. Is the nursing station where HDs may be stored included in "entities"?
  6. What is required of a nursing home for drug storage and administration?
  7. In a nursing home, are there requirements for the patient's room/apartment?
  8. What mechanism is to be used to gain compliance by all the non-pharmacy facilities (physician's offices, nursing homes, retirement centers, etc.)?

RESPONSIBILITIES OF PERSONNEL HANDLING HAZARDOUS DRUGS

  1. Where does the DESIGNATED PERSON obtain the necessary training for this job?
  2. How much training is "sufficient" for a DESIGNATED PERSON?
  3. How much time will be required for the DESIGNATED PERSON to do these activities each week?
  4. How many "support personnel" will be required to maintain records, etc.?
  5. How will the "action limits" be set for establishing "risks"?

FACILITIES AND ENGINEERING CONTROLS

  1. Is it necessary to post a sign at the front door to the store that HDs are in the pharmacy?
  2. If not, at what point is posting required?
  3. Regarding inventory segregation, I can't seem to find the location of the rule indicating we are required to keep 2 sets of inventory, one for CSPs and another for nonsterile preparations. Can you tell me where it is?
  4. Does the separate storage requirements also apply to patient care areas (nursing stations, etc.) since they may do a manipulation prior to or during administration, to delivery vehicles, etc.?
  5. Section 5.2 states that "Refrigerated antineoplastic HDs must be stored in a dedicated refrigerator in a negative pressure area�". Can "refrigerated non-antineoplastic HDs also be stored in that refrigerator or is a separate refrigerator required?

COMPOUNDING

  1. Regarding the USP <800> requirement to vent the SEC room outside, this may require a building permit since construction on a facility is involved. What recourse is there for the pharmacy if the city/county building permit to install an EXHAUST VENT from a HAZARDOUS compounding room in the pharmacy is denied?
  2. Owner in a community pharmacy (present a lot of the hours but not all the time) provides compounding services and has one pharmacist and a tech. Facility is set up for 800 compounding.
    • Is it necessary for the compounding pharmacist to remove ALL personal protective equipment (PPE) when they step out to answer the phone:
    • Can they just de-glove if they answer a "handsfree" phone inside the room?
    • The compounding pharmacist does all the patient counseling when new Rx's are picked up; does the pharmacist have to remove ALL PPE each time during the day for this?
  3. There is a debate on whether nonhazardous and hazardous compounding can take place in separate hoods (C-PEC) inside the same room (C-SEC) or do they have to be in separate rooms (C-SEC)?
    • In other words, do you have to have a hazardous room and a nonhazardous room?
    • If so, do they both need sinks?
    • This is going to be so difficult to do in the majority of facilities. I'm looking at upwards of $50,000 to renovate my lab. If we have to build separate rooms for nonhazardous and hazardous compounding, I'm not sure I can even do that in my current facility. I can't afford a new facility.
  4. What does it mean when it states "A sink must be available for hand washing"? This is in reference to the C-PEC and C-SEC? Does "available" mean there must be a sink inside the C-SEC or can it be outside?
  5. We are starting to remodel and still have questions. I have heard there may be changes to USP <800> that will impact our remodel operations. I don't want to spend money needlessly so how can we find out any changes quickly?
  6. Regarding 5.3.1, if I only handle HD liquids or semisolids where no particles, aerosols or gases are produced, must this be done in a negative pressure room?


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

 

NEW

More SOPs releated to USP <800> were posted to www.CompoundingToday.com this week!

 

IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

Learn about the Journal's new multi-media features and view our growing collection of educational and training videos at www.ijpc.com/video or by subscribing to our Youtube channel at https://www.youtube.com/user/IJPCompounding.

 

Did You Know ...

�that market research is what you call it when you already know the answer you want, but still make up a question that will produce it?

 

Tip of the Week

It is essential for men of science to take an interest in the administration of their own affairs or else the professional civil servant will step in-and then the Lord help you. (Ernest Rutherford [1871-1937]).

 

Looking Back

Leap year's over,
Your're safe now men,
All you cowards,
Can shave again!
     Burma Shave

Copyright 2016
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com